Literature DB >> 20572310

Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes.

Tan To Cheung1, Kelvin K Ng, Kenneth S Chok, See Ching Chan, Ronnie T Poon, Chung Mau Lo, Sheung Tat Fan.   

Abstract

AIM: To analyze the combined treatment of resection and intraoperative radiofrequency ablation (RFA) for multifocal hepatocellular carcinoma in terms of prognosis and surgical outcomes.
METHODS: This study was a retrospective case comparison study using prospectively collected data. The study covered the period from April 2001 to December 2006. The data of 200 patients with histologically confirmed hepatocellular carcinoma were reviewed. Nineteen patients (17 men and 2 women) having received resection in combination with RFA were chosen as subjects of the study (the combination group). Fifty-four patients (43 men and 11 women) having received resection alone were selected for comparison (the resection group). The two groups matched tumor number and tumor size, and all the patients in the two groups displayed no tumor rupture, major vascular involvement and distant metastasis. Their demographics, preoperative assessment, disease recurrence patterns, overall survival and disease-free survival were compared.
RESULTS: In the combination group, the median age was 65 years (range, 34-77 years), the median tumor number was 3 (range, 2-9), and the median tumor size was 6 cm (range, 1.2-14 cm). In the resection group, the median age was 51.5 years (range, 27-80 years, P = 0.003), the median tumor number was 3 (range, 2-9, P = 0.574), and the median tumor size was 6 cm (range, 1-14 cm, P = 0.782). The two groups were similar in characteristics of tumors and comorbidities, and had comparable results in preoperative liver function tests. All patients had Child-Pugh class A status. Bilobar involvement occurred in 14 patients (73.6%) in the combination group and 3 patients (5.5%) in the resection group (P = 0.04). Six patients (32%) in the combination group and 35 patients (65%) in the resection group underwent major hepatectomy. Thirteen patients (68%) in the combination group and 19 patients (35%) in the resection group underwent minor hepatectomy (P = 0.012). The combination group had fewer major resections (32% vs 65%, P = 0.012), less blood loss (400 vs 657 mL, P = 0.007), shorter operation time (270 vs 400 min, P = 0.001), and shorter hospital stay (7 vs 8.5 d, P = 0.042). The two groups displayed no major differences in surgical complications (15.8% vs 31.5%, P = 0.24), disease recurrence (63.2% vs 50%, P = 0.673), hospital mortality (5.3% vs 5.6%, P = 1), and overall survival (53 vs 44.5 mo, P = 0.496).
CONCLUSION: Safe and effective for selected patients with multifocal hepatocellular carcinoma, the combination of resection and intraoperative RFA widens the applicability of surgical intervention for the disease.

Entities:  

Mesh:

Year:  2010        PMID: 20572310      PMCID: PMC2890947          DOI: 10.3748/wjg.v16.i24.3056

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?

Authors:  Ronnie Tung Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Kei Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; John Wong
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

Review 3.  Radiofrequency ablation of primary and metastatic liver tumors.

Authors:  Steven A Curley; Francesco Izzo
Journal:  Surg Technol Int       Date:  2002-09

Review 4.  Radiofrequency thermal ablation of hepatocellular carcinoma.

Authors:  T Livraghi; S Lazzaroni; F Meloni
Journal:  Eur J Ultrasound       Date:  2001-06

5.  Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma.

Authors:  Yujin Hoshida; Yasushi Shiratori; Yukihiro Koike; Shuntaro Obi; Keisuke Hamamura; Takuma Teratani; Shuichiro Shiina; Masao Omata
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

6.  Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.

Authors:  R T Poon; S T Fan; C M Lo; I O Ng; C L Liu; C M Lam; J Wong
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

Review 7.  Radiofrequency ablation of primary and metastatic hepatic malignancies.

Authors:  Steven A Curley; Francesco Izzo
Journal:  Int J Clin Oncol       Date:  2002-04       Impact factor: 3.402

Review 8.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

9.  Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; Irene Oi-Lin Ng; John Wong
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

10.  Hepatic resection for bilobar hepatocellular carcinoma: is it justified?

Authors:  Chi-Leung Liu; Sheung-Tat Fan; Chung-Mau Lo; Irene Oi-Lin Ng; Ronnie Tung-Ping Poon; John Wong
Journal:  Arch Surg       Date:  2003-01
View more
  27 in total

1.  Low expression of GNAI3 predicts poor prognosis in patients with HCC.

Authors:  Guodong Chen; Xiaoyan Li; Gengsheng He; Zijian Yu; Jiaxing Luo; Jun He; Zonghai Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Number of nodules, Child-Pugh status, margin positivity, and microvascular invasion, but not tumor size, are prognostic factors of survival after liver resection for multifocal hepatocellular carcinoma.

Authors:  Brian K P Goh; Pierce K H Chow; Jin-Yao Teo; Jen-San Wong; Chung-Yip Chan; Peng-Chung Cheow; Alexander Y F Chung; London L P J Ooi
Journal:  J Gastrointest Surg       Date:  2014-05-23       Impact factor: 3.452

3.  Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Fei-Xiang Wu; Hang Li
Journal:  Tumour Biol       Date:  2014-09-09

Review 4.  Therapeutic options for intermediate-advanced hepatocellular carcinoma.

Authors:  Zong-Ming Zhang; Jin-Xing Guo; Zi-Chao Zhang; Nan Jiang; Zhen-Ya Zhang; Li-Jie Pan
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

5.  Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.

Authors:  Ji Ma; Tengfei Li; Xinwei Han; Huifeng Yuan
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-10       Impact factor: 4.553

6.  Hepatic resection combined with radiofrequency ablation versus hepatic resection alone for multifocal hepatocellular carcinomas: A meta-analysis.

Authors:  Liang-Liang Xu; Ming Zhang; Peng-Sheng Yi; Xiao-Bo Zheng; Lei Feng; Chuan Lan; Jian-Wei Tang; Sheng-Sheng Ren; Ming-Qing Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 7.  An overview in management of hepatocellular carcinoma in Hong Kong using the Hong Kong Liver Cancer (HKLC) staging system.

Authors:  Arnold Man Nok Chui; Thomas Chung Cheung Yau; Tan To Cheung
Journal:  Glob Health Med       Date:  2020-10-31

Review 8.  Hong Kong consensus recommendations on the management of hepatocellular carcinoma.

Authors:  Ronnie Tung-Ping Poon; Tom Tan-To Cheung; Philip Chong-Hei Kwok; Ann-Shing Lee; Tat-Wing Li; Kwok-Loon Loke; Stephen Lam Chan; Moon-Tong Cheung; Tak-Wing Lai; Chin-Cheung Cheung; Foon-Yiu Cheung; Ching-Kong Loo; Yiu-Kuen But; Shing-Jih Hsu; Simon Chun-Ho Yu; Thomas Yau
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

9.  Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.

Authors:  Xi Xu; Xingyu Pu; Li Jiang; Yang Huang; Lunan Yan; Jiayin Yang; Tianfu Wen; Bo Li; Hong Wu; Wentao Wang
Journal:  J Cancer Res Clin Oncol       Date:  2020-08-27       Impact factor: 4.553

Review 10.  Value of radiofrequency ablation in the treatment of hepatocellular carcinoma.

Authors:  Kai Feng; Kuan-Sheng Ma
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.